SCHEMBL20607282

SCHEMBL20607282

CCCCN1C(=O)NC(=O)C(CC)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.37
ABL1 P00519 2/20 0.37
RIN1 Q13671 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
GAA P10253 2/20 0.37
CYP19A1 P11511 2/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
PTGS1 P23219 3/20 0.35
PTGS2 P35354 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6327634 0.95 PTGS1 (0.42) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL1426485 0.81 LMNA (0.41) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL3152073 0.80 SMN1; SMN2 (0.42) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL20047912 0.80 SMN1; SMN2 (0.35) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL15978110 0.79 MMP1 (0.52) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL14660249 0.78 ALDH1A1 (0.44) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL20048140 0.78 POLB (0.51) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL9363498 0.76 ALDH1A1 (0.38) KDM4EMEN1ALDH1A1MAPTPKM
SCHEMBL2851785 0.75 ALDH1A1 (0.41) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT
SCHEMBL20048230 0.74 MAPT (0.45) SMN1; SMN2KDM4EMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423034-A1 ABUSE-DETERRENT PHARMACEUTICAL COMPOSITION G.L. Pharma GmbH (AT) 2019-01-09 EP disclosed
CN-1863513-A Abuse-proffed dosage form GRUENENTHAL GMBH (DE) 2006-11-15 CN disclosed
CN-1863514-A Abuse-proffed dosage form GRUENENTHAL GMBH (DE) 2006-11-15 CN disclosed
CN-1179418-A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists HOECHST AG (DE) 1998-04-22 CN disclosed